Chronic Pain News and Research

RSS

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA).

9 Jun 2014

Study defines how our ability to identify spatial acuity varies across the body

"Where does it hurt?" is the first question asked to any person in pain. A new UCL study defines for the first time how our ability to identify where it hurts, called "spatial acuity", varies across the body, being most sensitive at the forehead and fingertips.

9 Jun 2014

Liposuction expert offers treatment for patients suffering from lipedema

Liposuction expert Dr. David Amron is one of the select surgeons in the nation to successfully treat lipedema (a.k.a. lipoedema), a potentially debilitating condition that causes abnormal accumulation of fat cells in the legs and sometimes arms.

6 Jun 2014

Naloxegol holds hope for opioid-induced constipation

Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help, according to study led by the University of Michigan Health System.

5 Jun 2014

2014 PAINWeekEnd Regional Conference to be held in Tarrytown, NY

There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.

4 Jun 2014

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP compliant monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland. T

4 Jun 2014

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

3 Jun 2014

Risk-based preventive measures lower frequency of postoperative blood clots

Surgery patients are much less likely to get a blood clot in the lower extremities or lungs if they receive preventive treatment based on their individual clotting risk, in addition to walking soon after the operation.

3 Jun 2014

Study uncovers marijuana's potential to treat autoimmune diseases

A team of University of South Carolina researchers led by Mitzi Nagarkatti, Prakash Nagarkatti and Xiaoming Yang have discovered a novel pathway through which marijuana can suppress the body's immune functions. Their research has been published online in the Journal of Biological Chemistry.

3 Jun 2014

$Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma$

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

2 Jun 2014

Internalized stigma negatively linked with poor self-esteem and personal control of pain

Results of an Australian study published in The Journal of Pain showed that after controlling for depression internalized stigma is negatively associated with lower levels of self-esteem and personal control of pain.

31 May 2014

Positive activities administered online can lead to lasting reductions in bodily pain

Positive activities, such as increasing supportive emotions, can reduce body discomfort in adults with mild to moderate chronic pain, according to research reported in The Journal of Pain, the peer-reviewed publication of the American Pain Society, www.amercianpainsociety.org.

31 May 2014

NeuroMetrix announces marketing launch of NC-Stat DPNCheck in Japan

NeuroMetrix, Inc., an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today reported the marketing launch in Japan of NC-stat® DPNCheck®.

22 May 2014

UNC researchers find new enzyme target for treating chronic pain

Researchers at the UNC School of Medicine have found a new target for treating chronic pain: an enzyme called PIP5K1C.

22 May 2014

New online training module greatly improves medical student clinical skills

An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.

22 May 2014

Holistic exercise program may improve physical, psychological wellbeing of dementia patients

While dementia patients can often suffer from depression and declining physical and mental ability, exercise has been shown to help improve both their physical and psychological wellbeing.

20 May 2014

Innate immune response may warn of chronic multisite musculoskeletal pain

An enhanced innate immune response may be an indicator of the onset or prolongation of chronic, multisite musculoskeletal pain, cross-sectional study findings suggest.

19 May 2014

Majority of Americans experience foot pain, shows new study

The American Podiatric Medical Association (APMA) today announced the results of its Today's Podiatrist survey, which measures the public's attitudes toward foot health.

19 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

Researchers show how cone snails venom inhibits neuronal calcium channels to reduce neuropathic pain

The venom from marine cone snails, used to immobilize prey, contains numerous peptides called conotoxins, some of which can act as painkillers in mammals. A recent study in The Journal of General Physiology provides new insight into the mechanisms by which one conotoxin, Vc1.1, inhibits pain.

15 May 2014

Chronic Pain News and Research

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Study defines how our ability to identify spatial acuity varies across the body

Liposuction expert offers treatment for patients suffering from lipedema

Naloxegol holds hope for opioid-induced constipation

2014 PAINWeekEnd Regional Conference to be held in Tarrytown, NY

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Risk-based preventive measures lower frequency of postoperative blood clots

Study uncovers marijuana's potential to treat autoimmune diseases

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Internalized stigma negatively linked with poor self-esteem and personal control of pain

Positive activities administered online can lead to lasting reductions in bodily pain

NeuroMetrix announces marketing launch of NC-Stat DPNCheck in Japan

UNC researchers find new enzyme target for treating chronic pain

New online training module greatly improves medical student clinical skills

Holistic exercise program may improve physical, psychological wellbeing of dementia patients

Innate immune response may warn of chronic multisite musculoskeletal pain

Majority of Americans experience foot pain, shows new study

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

Researchers show how cone snails venom inhibits neuronal calcium channels to reduce neuropathic pain

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News